Biomarkers Products & Reviews

2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-6)

COVID-19, MERS & SARS-CoV, Nucleoprotein Antibody, 1057

COVID-19, MERS & SARS-CoV, Nucleoprotein Antibody, 1058

SARS-CoV-2 Nucleocapsid, clone 504 Monoclonal Antibody (matched pair with clone 502 or 503)

SARS-CoV-2 Nucleocapsid, clone 2A1 Monoclonal Antibody (matched pair with clone 2C1)

SARS-CoV-2 Nucleocapsid, clone 2C1 Monoclonal Antibody (matched pair with clone 2A1)

SARS-CoV-2 Nucleocapsid, clone 4D8 Monoclonal Antibody (matched pair with clone 5B7)

SARS-CoV-2 Nucleocapsid, clone 5B7 Monoclonal Antibody (matched pair with clone 4D8)

SARS-CoV-2 Nucleocapsid,clone 7B3 Monoclonal Antibody (matched pair with clone 5D4)

SARS-CoV-2 Nucleoprotein (aa 1-419) Recombinant Antigen, 613

SARS-CoV-2 Spike (RBD, aa 331-524) Recombinant Antigen

SARS-CoV-2 Spike Protein S1 (aa 1-674) Recombinant Antigen

Biomarker assay kits

Accelerating radiopharmaceutical development in oncology

BioIVT has the expertise in the processes required for ethical acquisition of biospecimens that cover a wide range of disease states and the protocols needed to produce reliable data. With over 425 IRB-approved clinical sites, BioIVT provides clinical specimens for nearly all disease states.

BioIVT supplies high quality, ready to ship or custom plasma, serum, and whole blood—both normal and disease-state—collected from a diverse pool of consented donors under IRB-approved protocols or a wide variety of species.

As the world's largest private repository of human cerebrospinal fluid, BioIVT’s Center for NeuroExcellence offers 35,000+ healthy and 113,000+ diseased donor samples allowing for comparative studies and precise control matching. The samples are ethically collected following strict quality standards and feature detailed clinical data and matching blood, plasma, or sera.

Complement biomarker assays target selected biomarkers of high relevance. These assays are important and well-suited for analyses in drug development and academic research. They stand out with very low cross-reactivity and high specificity as they bind neo-epitopes of cleaved products or complexes, where this is relevant.

Engineered, homologous, and specific target cells that enable screening for antibody-induced effector functions.

The iLite® CD3 Effector Cell line is a reporter gene cell line that offers a convenient and powerful way of measuring the efficacy antibodies have to elicit  T cell activation through CD3  interactions.

The Complement TCC is a flexible and easy to use immunoassay for determination of the terminal complement complex (TCC, also known as sC5b-9) in human plasma.

The Complement C4d assay is a highly specific C4d ELISA kit for measurement of C4d in human plasma. The assay targets a unique cleavage epitope on C4d, which means that only the C4d is measured.

The Factor P Quantitative Assay is a sandwich ELISA for quantifying human Factor P (Properdin) in, serum or plasma samples.

Expert Biomarker Discovery Services using cutting-edge technologies such as high-quality proteomics with Proximity Extension Assay (PEA) technology from Olink, and ultra-sensitive detection with proven Simoa technology. We offer ideal broad screening-to-targeted biomarker discovery solutions in different therapeutic areas.

A specialized and GxP-certified laboratory for Bioanalytical Service Solutions -with scientific expertise & advanced technologies. We offer assay development, validation, and sample analysis of pharmacokinetics, toxicokinetic, pharmacodynamics, immunogenicity, and biomarker analysis.